Auxilium Pharmaceuticals (P/C Chart, news, volatility) has been moving steadily higher and shares are up $2.10 to four-month high of $33.80. There is no company specific news and the strength is perhaps a reflection of renewed intrerest in biotech names following recent rallies in a number of small/mid-cap names including ITMN, OSIP, and GERN. Options traders are also active, with 4,550 calls and 230 puts traded on AUXL today. Looks like selling in the Feb 40s, buying in June 40s and March 35s.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.